Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 08 2019
Historique:
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 17 6 2020
Statut: epublish

Résumé

An increase in opioid prescription has been observed in the Netherlands. It is vital to understand this increase and to identify risk factors for opioid prescription to ensure that health interventions remain appropriately targeted. To determine the prevalence of opioid prescriptions and adverse events associated with opioids, and to identify risk factors associated with opioid prescription in the Dutch population. This cohort study used national statistics from the Netherlands from January 1, 2013, to December 31, 2017, including the full Dutch population of 16 779 575 people in 2013 and 17 081 507 people in 2017. Data from the Dutch Health Monitor surveys of 2012 and 2016 were also included. Databases were anonymized prior to analysis. All analyses were performed between December 2018 and February 2019. Opioid prescription. The main outcomes were the dynamics of opioid prescriptions, hospital admissions for opioid overdose, and opioid overdose mortalities. The secondary outcome was risk factors associated with opioid prescription. In 2013, 814 211 individuals (4.9% of the total population) received an opioid prescription. In 2017, 1 027 019 individuals (6.0% of the total population) received at least 1 opioid prescription (mean [SD] age, 59.3 [18.5] years; 613 203 [59.7%] women). The rate of hospital admissions for opioid overdose was 9.2 per 100 000 inhabitants in 2013 and 13.1 per 100 000 inhabitants in 2017 (relative risk, 1.43 [95% CI, 1.34-1.52]). Similarly, an increased risk of opioid overdose death was observed, from 0.83 per 100 000 inhabitants in 2013 to 1.2 per 100 000 inhabitants in 2017 (relative risk, 1.49 [95% CI, 1.20-1.85]). Based on data from the 2012 Dutch Health Monitor survey, risk factors associated with opioid prescription included being older than 65 years (odds ratio [OR], 4.20 [95% CI, 3.98-4.43]), having only a primary school education (OR, 3.62 [95% CI, 3.46-3.77]), being widowed (OR, 3.30 [95% CI, 3.13-3.49]), reporting always feeling symptoms of depression (OR, 3.77 [95% CI, 3.41-4.18]), and reporting poor or very poor physical health (OR, 10.40 [95% CI, 10.01-10.81]). Self-reported back pain (OR, 4.34 [95% CI, 4.23-4.46]) and rheumatoid arthritis or fibromyalgia (OR, 3.77 [95% CI, 3.65-3.90]) were also associated with opioid prescription. However, unemployment (OR, 1.05 [95% CI, 0.96-1.13]) was not associated with opioid prescription, and alcohol use disorder (OR, 0.76 [95% CI, 0.73-0.80]) was negatively associated with opioid prescription. This study found that opioid prescriptions have increased in the Netherlands. Although the risk of adverse events is still relatively low, there is an urgent need to review pain management to prevent a further increase in opioid prescription.

Identifiants

pubmed: 31461149
pii: 2749053
doi: 10.1001/jamanetworkopen.2019.10223
pmc: PMC6716286
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1910223

Références

Br J Pharmacol. 2006 Jan;147 Suppl 1:S153-62
pubmed: 16402099
Pain. 2008 Sep 15;138(3):507-13
pubmed: 18342447
J Pain. 2012 Mar;13(3):266-75
pubmed: 22285611
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52
pubmed: 22588748
Curr Pharm Des. 2012;18(37):5994-6004
pubmed: 22747535
Ned Tijdschr Geneeskd. 2013;157(49):A7005
pubmed: 24299631
MMWR Morb Mortal Wkly Rep. 2014 Oct 10;63(40):881-5
pubmed: 25299603
BMC Musculoskelet Disord. 2015 Feb 07;16:18
pubmed: 25768862
Psychosom Med. 2015 Apr;77(3):333-41
pubmed: 25849129
J Addict Dis. 2016;35(1):42-51
pubmed: 26566771
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83
pubmed: 26575631
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
JAMA Intern Med. 2016 Jul 1;176(7):958-68
pubmed: 27213267
BMC Public Health. 2016 Sep 30;16(1):1034
pubmed: 27716147
Natl Vital Stat Rep. 2016 Dec;65(10):1-15
pubmed: 27996932
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Addiction. 2017 Sep;112(9):1558-1564
pubmed: 28191702
Bone Joint J. 2017 Jul;99-B(7):856-864
pubmed: 28663389
MMWR Morb Mortal Wkly Rep. 2017 Jul 07;66(26):697-704
pubmed: 28683056
Alcohol Clin Exp Res. 2018 Mar;42(3):478-488
pubmed: 29314075
JAMA. 2018 Mar 6;319(9):872-882
pubmed: 29509867
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):279-285
pubmed: 29518069
ACS Chem Neurosci. 2018 Oct 17;9(10):2503-2518
pubmed: 30247870
JAMA Psychiatry. 2019 Feb 1;76(2):208-216
pubmed: 30516809
JAMA. 2018 Dec 18;320(23):2448-2460
pubmed: 30561481
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427
pubmed: 30605448
JAMA Netw Open. 2019 Jan 4;2(1):e186007
pubmed: 30657529
Addict Behav. 2019 May;92:225-235
pubmed: 30685521
JAMA Intern Med. 2019 Apr 1;179(4):469-476
pubmed: 30742196

Auteurs

Ajda Bedene (A)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Willem M Lijfering (WM)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Marieke Niesters (M)

Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Monique van Velzen (M)

Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Frits R Rosendaal (FR)

Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.

Marcel L Bouvy (ML)

Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands.

Albert Dahan (A)

Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Eveline L A van Dorp (ELA)

Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH